tirzepatide from eli lilly Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth FDA approval for Zepbound (tirzepatide)

Antonia Ehlers, a spokesperson for Kaiser, said the strike disrupted care and service for our members and came at a significant cost at a time when keeping care affordable is more important than ever. During the strike, spokespersons said the unions $3 billion pay proposal would force Kaiser, Californias largest private health insurer, to raise prices on members and customers

It is unknown whether the issue was triggered by the medication and may be a coincidence, so more research is needed

Wellness shots, on the other hand, take only a few minutes

Lilly estimates 4.5 million people take one of the Indianapolis drugmaker's GLP-1 medicines to lose weight or curb other health concerns like sleep apnea